Presentation is loading. Please wait.

Presentation is loading. Please wait.

December 20111 JP Sammut Director, EuroMedITI - Technology Commercialisation Commercialisation Programme 2012 Information Session.

Similar presentations


Presentation on theme: "December 20111 JP Sammut Director, EuroMedITI - Technology Commercialisation Commercialisation Programme 2012 Information Session."— Presentation transcript:

1 December 20111 JP Sammut Director, EuroMedITI - Technology Commercialisation Commercialisation Programme 2012 Information Session

2 Commercialisation Programme 2012 Scope March 20122 The Programme will help participants access specialist advice to prepare a viable business plan for their technology to be ready for, and attract, capital investment. The programme is most suited for those new to commercialisation who believe that their technology has commercial potential, but are unsure what to do next. The funds will be allocated on the basis of a public call for proposals and an external peer review system.

3 March 20123 The National R&I Programme Programme Participation Programme Total Proposals Requested Funding Available Budget Total Projects Funded RTDI 2004 85 € 7.0M € 700K15 R&I 2006 58 € 7.0M € 930K7 R&I 2008 40 € 5.4M € 700K7 R&I 2009 17 €1.5M€1.5M € 300K3 R&I 2010 40 € 5.8M € 700K5 R&I 2011 40 € 5.8M € 1.1M8

4 March 20124 Focus on 4 Priority Areas 1.Environment and Energy Resources 2.Information and Communications Technology 3.Value-added Manufacturing and Services 4.Health and BioTechnology Typical Project Activities Business and IP planning; Commercialisation validation; Capital sources and Business linkages Commercialisation Programme 2012 Focus

5 March 20125 Participant – An Individual Organisation or a team of Members Members can be academia, public, private, NGOs - eligible for funding Foreign entities eligible but not funded Commercialisation Programme 2012 Participation

6 March 20126 Eligible Direct Costs –Technical personnel –Project Management –Travel, networking, dissemination, externalization –Subcontracting –Other Expenses related to the project (e.g. Demonstration set-ups) Eligible Indirect Costs –10% of eligible costs, excluding subcontracting. Funding Modalities Eligible Costs

7 March 20127 Ineligible Direct Costs –Product Development –Equipment –Expenses related to loans, interest, etc –Recoverable value added tax. –Expenses which are recoverable through other funding mechanisms Funding Modalities Ineligible Costs

8 March 20128 Process Written Proposal submission Shortlisted Participants Advised Shortlisted Participants Presentation Funding offered to successful Participants 25/04/2012, noon 30/05/2012 14/06/2012 27/07/2012

9 March 20129 1. Programme Objectives –Degree of fit with priority sectors –Meeting a market opportunity 2. Status –Technology Development –Product Development –IP Agreement –Business approach –Proposes suitable actions Four Evaluation Criteria

10 March 201210 3. Quality of Participant –Participants have necessary knowledge and skills –Balanced participation and funding 4. Potential Impact –Application and uses of technology/ product –Degree for potential Commercialisation. –Roadmap for realisation of benefits –Spillover effects on local economy –Other Benefits Cost Reduction Licensing Networking Organisational Benefits Evaluation Criteria cont.

11 March 201211 Project funding: €25K – €75K Project duration: 6 – 12 months Funding levels –Public, Academic, NGO: 100% –Business: 75% Funding Modalities Project Funding

12 March 201212 The share of the project costs between the Members in the project Participant reflect the ratio of IP share as detailed in the IP agreement Ownership of IP and all rights rests with participants Project Considerations Intellectual Property (IP)

13 March 201213 Funding Modalities Allocation of funds Typical Initial advanced payment 80% unless split into stages- where next stage funding depends on success of previous stage; Retention of 20% of total project grant depending on successful progress/ final reporting

14 March 201214 Participants must maintain separate financial accounts and separate bank account Actual costs with fiscal receipts Costs determined in accordance with usual accounting and management procedures Expenses must be consistent with principles of economy, efficiency and effectiveness Refundable expenses limited to allocation Project Considerations Financial Considerations

15 March 201215 Project Considerations During Project Need for professional record keeping and auditing Significant events – inform MCST Withdrawal of member – agree with MCST for reallocation or replacement Default – MCST entitled to withdraw funding and claim refund

16 March 201216 Electronic Submissions to commercialisatiion.mcst@gov.mt commercialisatiion.mcst@gov.mt OneOne single application file in Ms Word (.doc) format (without signatures) OneOne single application file in Portable Document Format (.pdf) (includes a scanned signed copy of the Participant Details Section for each participant + initialisation of every page) OneOne single Technology Profile file in Power Point (.ppt) format (without signatures) Files limited to 5MB per file All received proposals acknowledged by email Submissions of Proposals

17 March 201217 Commercialisation Programme 2012 State Aid Operates under de minimis state aid regime: –Projects in fisheries, aquaculture and agriculture ineligible –Industry to ensure they do not exceed allowable limit of aid (€200K gross over 3-year period) –Necessary reporting required Double funding not allowed – checks are conducted

18 March 201218 For Further Information Contact: JP Sammut Director, EuroMedITI – Technology Commercialisation Malta Council for Science and Technology Villa Bighi, Bighi Kalkara, KKR1320 Email: joseph.p.sammut@gov.mt Tel: (356) 2360 2127 Web:www.mcst.gov.mt Thank You


Download ppt "December 20111 JP Sammut Director, EuroMedITI - Technology Commercialisation Commercialisation Programme 2012 Information Session."

Similar presentations


Ads by Google